Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol

Journal of Medicinal Food

Volumn 7, Issue 2, 2004, Pages 168-179

  Benlhabib, Elhabib ^a   Baker, John I ^b   Keyler, Daniel E ^b,c   Singh, Ashok K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alcohol withdrawal; Alcohol preferring rats; Blood brain barrier; High pressure liquid chromatography; Isoflavones; Kudzu root; NMDA and GABA; Opioid receptors; Puerarin

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; DAIDZEIN; DAIDZIN; GENISTEIN; GLYCITEIN; ISOFLAVONE; KUDZU ROOT EXTRACT; N METHYL DEXTRO ASPARTIC ACID; PLANT EXTRACT; PUERARIN; UNCLASSIFIED DRUG; WATER;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG HYDROLYSIS; DRUG METABOLISM; FEMALE; FLUID INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERSENSITIVITY; MOTOR COORDINATION; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; RAT; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ALCOHOL DRINKING; ANIMALS; ANXIETY; BODY WEIGHT; BRAIN CHEMISTRY; DRINKING; EATING; ETHANOL; FEMALE; ISOFLAVONES; LIVER; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PUERARIA; RATS; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; PUERARIA MONTANA VAR. LOBATA;

EID: 3042839159     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/1096620041224210     Document Type: Article

References (42)

1. Hunt WA: Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism? A review. Alcohol Clin Exp Res 1993;17:1055-1065.
2. Rice DP, Kelman S, Miller LS, Dunmeyer S: The Economic Cost to Society of Alcohol and Drug Abuse and Mental Illness, Superintendent of Documents, U.S. Government Printing Office, Washington, DC, 1993.
3. Froehlich JC, Badia-Elder NE, Zink RW, McCullough DE, Portoghese PS: Contribution of the opioid system to alcohol aversion and alcohol drinking behavior. J Pharmacol Exp Ther 1998;287:284-292.
4. Froehlich JC, Wand GS: The neurobiology of ethanol-opioid interaction in ethanol reinforcement. Alcohol Clin Exp Res 1997;20(Suppl):181A-186A.
5. Froehlich JC, Harts J, Lumeng L, Li T-K: Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 1991;35:385-390.
6. Hyytia P: Involvement of μ opioid receptors in alcohol drinking by alcohol preferring AA rats. Pharmacol Biochem Behav 1993;45:697-701.
7. Jones EA, Dekker LR: Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 2000;118:431-432.
8. O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor PG: Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol 2000;20:69-76.
9. Oncken C, Van Kirk J, Kranzler HR: Adverse effects of oral naltrexone: analysis of data from two clinical trials. Psychopharmacology 2001;154:397-402.
10. Janning P, Scuhmacher US, Upmeier A, Diel P, Michna H, Degen GH, Bilt HM: Toxicokinetics of the phytoestrogen daidzein in female DA/Han rats. Arch Toxicol 2000;74:421-430.
11. Keung W-M, Vallee BL: Diadzin and diadzein suppress free choice ethanol intake by Syrian golden hamsters. Proc Natl Acad Sci U S A 1993;90:10008-10012.
12. Overstreet DH, Lee DY-W, Chen YT, Rezvani AH: The Chinese herbal medicine NPI-028 suppresses alcohol intake in alcohol-preferring rats and monkeys without inducing taste aversion. Perfusion 1998;11:381-390.
13. Overstreet DH, Lee YW, Rezvani AH, Chriswell HE, Janowsky DS: Suppression of alcohol intake following administration of the Chinese herbal medicine, NPI-028 and its derivatives. Alcohol Clin Exp Res 1996;20:221-227.
14. Lin RC, Guthrie S, Xie C-Y, Mai K, Lee DY, Lumeng L, Li T-K: Isoflavonoid compounds extracted from Pueraria lobata suppresses alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 1996;20:659-663.
15. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988;242:715-723.
16. Koob GF, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science 1997;278:52-58.
17. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P, Merlo-Pich E, Weiss F: Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 1988;22:3-9.
18. Pandey S, Saito T, Yoshimura M, Sohma H, Gotz ME: cAMP signaling cascade: a promising role in ethanol tolerance and dependence. Alcohol Clin Exp Res 2001;25(Suppl):46S-48S.
19. Williams D, Lewis J, McBride A: A comparison of rating scales for the alcohol-withdrawal syndrome. Alcohol Alcohol 2001;36:104-108.
20. Benlhabib E, Baker J, Keyler D, Singh AK: Composition, RBC uptake, and serum protein binding of phytoestrogens extracted from commercial kudzu-root and soy preparations. J Med Food 2002;5:109-123.
21. Lumeng L, Li T-K: The development of metabolic tolerance in the alcohol preferring P rats: comparison of forced and free-choice drinking of ethanol. Pharmacol Biochem Behav 1986;25:1013-1020.
22. American Psychiatric Association: Diagnosis and Statistical Manual of Mental Disorders (DSM-IV), 4th ed., American Psychiatric Association, Washington, DC, 1994.
23. Kampov-Povevoy AB, Matthews DB, Gause L, Morrow AL, Overstreet DH: P rats develop physiological dependence on alcohol via voluntary drinking: changes in seizure threshold, anxiety, and patterns of alcohol drinking. Alcohol Clin Exp Res 1000;24:278-284.
24. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT: CRG antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 1991;103:227-232.
25. File S, Baldwin HA, Hitchcott PK: Flumazenil but not nitrendipine reverses the increased anxiety in the rat. Psychopharmacology 1989;98:262-264.
26. Fujimiya T, Yamaoka K, Ohbora Y, Aki T, Shinagawa H: Michaelis-Menten elimination kinetics of acetaldehyde during ethanol oxidation. Alcohol Clin Exp Res 2002;26(Suppl): 49S-54S.
27. Videla L, Bernstein J, Israel Y: Metabolic alterations produced in the liver by chronic ethanol administration. Biochem J 1973;134:507.
28. Keyler DE, Baker JI, Lee DY-W, Overstreet DH, Boucher TA, Lenz SK: Toxicity study of an antidipsotropic Chinese herbal mixture in rats: NPI-028. J Altern Complement Med 2002;8:175-183.
29. 2C agonists. Pharmacol Biochem Behav 2002;75:619-625.
30. Qian Y, Li Z, Huang L, Han X, Sun J, Zhou H, Liu Z: Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes. Chin Med J 1999;112:787-789.
31. Watson WP, Little HJ: Selectivity of the protective effects of dihydropyridine calcium channel antagonist against the ethanol withdrawal syndrome. Brain Res 2002;930:111-122.
32. Knapp DJ, Overstreet DH, Breese GR: Persistent effects of repeated ethanol withdrawal are blunted by pharmacological treatments during early withdrawal episodes [abstract]. Alcohol Clin Exp Res 2001;25:23A.
33. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abott NJ, Rice-Evans C: Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003;85:180-192.
34. 3H] (-) epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19:1771-1776.
35. Al Qatari M, Khan S, Harris B, Littleton J: Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by alcohol withdrawal in neocortical cultures of fetal rat brain. Alcohol Clin Exp Res 2001;25:1276-1283.
36. Poddar MK, Bandyopadhyay BC, Chakrabarti L: Dietary protein alters age-induced changes in hypothalamic GABA and immune response. Neuroscience 2000;97:405-409.
37. Bandyopadhyay BC, Poddar MK: Hypothalamic GABAergic activity and T-cell proliferation in aged mammals: effects of dietary protein. Neurochem Int 1998;32:191-196.
38. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Polyenylphosphatidylcholine protects against alcohol but not iron-induced oxidative stress in the liver. Alcohol Clin Exp Res 2000;24:196-206.
39. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Polyenylphosphatidylcholine opposes the increase of cytochrome P4502E1 by ethanol and corrects its iron-induced decrease. Alcohol Clin Exp Res 1999;123:96-100.
40. Aleynik SI, Leo MA, Aleynik MK, Lieber CS: Alcohol-induced pancreatic oxidative stress: protection by phospholipid repletion. Free Radic Biol Med 1999;26:609-619.
41. Aleynik SI, Leo MA, Lieber CS: Polyunsaturated phosphatidylcholine (PC) incorporation into phospholipids is greater in pancreas than in liver and protects against alcohol-induced oxidative stress in both. Gastroenterology 1998;114:A1202-A1209.
42. Aleynik SI, Leo MA, Ma X, Aleynik MK, Lieber CS: Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 1997;27:554-561.